Abstract
The involvement of small nucleolar RNA host gene 3 (SNHG3) in cancer regulation has been reported. This study attempted to deeply investigate the molecular regulatory mechanism of SNHG3 on malignant progression of hepatocellular carcinoma (HCC). According to TCGA analysis, high SNHG3 expression was a risk factor for poor prognosis of HCC patients. Therefore, we further detected the mRNA level of SNHG3 in HCC tissue and cells. It was found that SNHG3 was upregulated in HCC tissue and cells. Afterwards, CCK-8 and flow cytometry assays further proved that silencing SNHG3 inhibited HCC cell proliferation while inducing cell apoptosis and G0/G1 phase arrest. It was also attested in vivo experiments that silencing SNHG3 could reduce the volume and weight of tumors and downregulate the Ki-67 expression to suppress HCC tumor growth. Next, it was discovered that SNHG3 increased the binding of E2F1 and NEIL3 promoter region, thereby activating the transcription feature of NEIL3. Lastly, rescue assays indicated that NEIL3 participated in SNHG3-mediated HCC cell cycle, apoptosis and proliferation. All in all, this study revealed the specific regulatory mechanism of SNHG3 in HCC to enable SNHG3 a hopeful marker for HCC diagnosis and treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and materials
The data that support the findings of this study are available on request from the corresponding author.
References
Allemani C et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023–1075. https://doi.org/10.1016/S0140-6736(17)33326-3
Cai B, Song XQ, Cai JP, Zhang S (2014) HOTAIR: a cancer-related long non-coding RNA. Neoplasma 61:379–391. https://doi.org/10.4149/neo_2014_075
Chang L et al (2018) SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1. Mol Med Rep 17:342–349. https://doi.org/10.3892/mmr.2017.7875
Chao Y, Zhou D (2019) lncRNA-D16366 is a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma. Med Sci Monit 25:6581–6586. https://doi.org/10.12659/MSM.915100
Chen J et al (2018) LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis. Aging (albany NY) 10:3371–3381. https://doi.org/10.18632/aging.101645
Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res 149:1–61. https://doi.org/10.1016/bs.acr.2020.10.001
Clark T, Maximin S, Meier J, Pokharel S, Bhargava P (2015) Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment. Curr Probl Diagn Radiol 44:479–486. https://doi.org/10.1067/j.cpradiol.2015.04.004
Fang Z et al (2019) YY1 promotes colorectal cancer proliferation through the miR-526b-3p/E2F1 axis. Am J Cancer Res 9:2679–2692
Fei F et al (2018) LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21. Biosci Rep 38. https://doi.org/10.1042/BSR20180420
Guo Y et al (2019) LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomed Pharmacother 118:109272. https://doi.org/10.1016/j.biopha.2019.109272
Hu YW et al (2018) LncRNA PLAC2 down-regulates RPL36 expression and blocks cell cycle progression in glioma through a mechanism involving STAT1. J Cell Mol Med 22:497–510. https://doi.org/10.1111/jcmm.13338
Huang MD et al (2015) Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2. J Hematol Oncol 8:50. https://doi.org/10.1186/s13045-015-0146-0
Huang W et al (2017) The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer. Oncol Rep 38:1402–1410. https://doi.org/10.3892/or.2017.5837
Iacovoni JS, Cohen SB, Berg T, Vogt PK (2004) v-Jun targets showing an expression pattern that correlates with the transformed cellular phenotype. Oncogene 23:5703–5706. https://doi.org/10.1038/sj.onc.1207737
Jalland CM et al (2016) Neil3 induced neurogenesis protects against prion disease during the clinical phase. Sci Rep 6:37844. https://doi.org/10.1038/srep37844
Koyasu S, Takakura S, Ichiyama S (2012) Emergency hospitalization caused by fever-70’s woman with short bowel syndrome. Kansenshogaku Zasshi 86:1–5
Krchnakova Z et al (2019) Splicing of long non-coding RNAs primarily depends on polypyrimidine tract and 5’ splice-site sequences due to weak interactions with SR proteins. Nucleic Acids Res 47:911–928. https://doi.org/10.1093/nar/gky1147
Li Y, Zhao Z, Liu W, Li X (2020) SNHG3 functions as miRNA sponge to promote breast cancer cells growth through the metabolic reprogramming. Appl Biochem Biotechnol 191:1084–1099. https://doi.org/10.1007/s12010-020-03244-7
Lin M et al (2019) E2F1 transactivates IQGAP3 and promotes proliferation of hepatocellular carcinoma cells through IQGAP3-mediated PKC-alpha activation. Am J Cancer Res 9:285–299
Liu X, Li D, Zhang W, Guo M, Zhan Q (2012) Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J 31:4415–4427. https://doi.org/10.1038/emboj.2012.292
Liu L, Ni J, He X (2018) Upregulation of the long noncoding RNA SNHG3 promotes lung adenocarcinoma proliferation. Dis Markers 2018:5736716. https://doi.org/10.1155/2018/5736716
Olsen MB et al (2017) NEIL3-dependent regulation of cardiac fibroblast proliferation prevents myocardial rupture. Cell Rep 18:82–92. https://doi.org/10.1016/j.celrep.2016.12.009
Sarveazad A, Agah S, Babahajian A, Amini N, Bahardoust M (2019) Predictors of 5 year survival rate in hepatocellular carcinoma patients. J Res Med Sci 24:86. https://doi.org/10.4103/jrms.JRMS_1017_18
Sherman M (2008) Recurrence of hepatocellular carcinoma. N Engl J Med 359:2045–2047. https://doi.org/10.1056/NEJMe0807581
Sun Q et al (2018) MIR100 host gene-encoded lncRNAs regulate cell cycle by modulating the interaction between HuR and its target mRNAs. Nucleic Acids Res 46:10405–10416. https://doi.org/10.1093/nar/gky696
Tang B et al (2021) Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden. J Adv Res 33:153–165. https://doi.org/10.1016/j.jare.2021.01.018
Torre LA et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108. https://doi.org/10.3322/caac.21262
Trimarchi JM, Lees JA (2002) Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3:11–20. https://doi.org/10.1038/nrm714
Wang Y et al (2019a) A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer 18:28. https://doi.org/10.1186/s12943-019-0957-7
Wang L, Su K, Wu H, Li J, Song D (2019b) LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis. Life Sci 232:116597. https://doi.org/10.1016/j.lfs.2019.116597
Wang H, Wang X, Xu L, Zhang J (2022) Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts. BMC Pediatr 22:376. https://doi.org/10.1186/s12887-022-03424-w
Wu D et al (2021) Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma. J Oncol 2021:1301671. https://doi.org/10.1155/2021/1301671
Xu TP et al (2017) E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis. Cell Death Dis 8:e2837. https://doi.org/10.1038/cddis.2017.205
Xuan Y, Wang Y (2019) Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation. Cell Death Dis 10:694. https://doi.org/10.1038/s41419-019-1940-3
Yong KJ et al (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med 368:2266–2276. https://doi.org/10.1056/NEJMoa1300297
Zhang T, Cao C, Wu D, Liu L (2016) SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma. Tumour Biol 37:2379–2385. https://doi.org/10.1007/s13277-015-4052-4
Zhao Q et al (2019) LncRNA SNHG3 promotes hepatocellular tumorigenesis by targeting miR-326. Tohoku J Exp Med 249:43–56. https://doi.org/10.1620/tjem.249.43
Zhao Z et al (2021) NEIL3 prevents senescence in hepatocellular carcinoma by repairing oxidative lesions at telomeres during mitosis. Can Res 81:4079–4093. https://doi.org/10.1158/0008-5472.Can-20-1028
Zheng S et al (2019) LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma. Biomed Pharmacother 112:108695. https://doi.org/10.1016/j.biopha.2019.108695
Zhou J et al (2017) NEIL3 repairs telomere damage during S phase to secure chromosome segregation at mitosis. Cell Rep 20:2044–2056. https://doi.org/10.1016/j.celrep.2017.08.020
Author information
Authors and Affiliations
Contributions
FB: conceptualization and methodology. J L: data curation and writing—original draft. J Y: formal analysis. QQ: investigation and resources. XF: software and validation. YF: visualization. CM: supervision and writing—editing. All authors reviewed and gave final approval of the version to be published.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was conducted in accordance with the Helsinki Declaration II and was approved by the Institutional Review Boards of Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University.
Consent for publication
Not applicable.
Conflicts of interest
All authors declare that they have no potential conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, F., Lu, J., Yang, J. et al. SNHG3 regulates NEIL3 via transcription factor E2F1 to mediate malignant proliferation of hepatocellular carcinoma. Immunogenetics 75, 39–51 (2023). https://doi.org/10.1007/s00251-022-01277-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-022-01277-2